Developmental origins of health and disease: The importance of environmental exposures

Early Life Origins of Human Health and Disease

Volumn , Issue , 2009, Pages 42-51

  Newbold, Retha ^a   Heindel Dr , Jerrold J ^b  

^a Division of Intramural Research   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882113450     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000221152     Document Type: Chapter

References (38)

1. Gluckman PD, Hanson MA, Beedle AS: Early life events and their consequences for later disease: a life history and evolutionary perspective. Am J Hum Biol 2007;19:1-19.
2. Miller KP, Gorgeest C, Greenfeld C, et al: In utero effects of chemicals on reproductive tissues in females. Toxicol Appl Pharmacol 2004;198:111-131.
3. Heindel J: Role of exposure to environmental chemicals in the developmental basis of reproductive disease and dysfunction. Semin Reprod Med 2005;24: 168-177.
4. Waterland RA, Michels KB: Epigenetic epidemiology of the developmental origins hypothesis. Annu Rev Nutr 2007;27:363-388.
5. Brosen K (ed): Basic and Clinical Pharmacology & Toxicology, Denmark, Wiley-Blackwell Publishing, 2008, vol 102.
6. Knudsen (ed): Reproductive Toxicology, Elsevier Publishing, 2007, vol 23.
7. Califat AM, Xiaoyun Y, Reidy JA, Needham L: Exposure of the U.S. population to Bisphenol A and 4-tertiary-octylphenol: 2003-2004. EHP 2008;116: 30-44.
8. Younglai EV, Foster WG, Hughes EG, et al: Levels of environmental contaminants in human follicular fluid, serum and seminal plasma of couples undergoing in vitro fertilization. Arch Environ Contam Toxicol 2002;43:121-126.
9. vom Saal FS, Akingbemi BT, Belcher SM, et al: Chapel Hill bisphenol A expert consensus panel statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 2007;24: 131-138.
10. Herbst AL, Ulfeder H, Poskanzer DC, Longo LD: Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. Am J Obstet Gynecol 1999;181: 1574-1575.
11. Palmer JR, Hatch EE, Rosenberg CL, et al: Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes Control 2002;13:753-758.
12. Swan SH: Intrauterine exposure to diethylstilbestrol: long-term effects in humans. APMIS 2000;108: 793-804.
13. Baird DD, Newbold R: Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol 2005;20:81-84.
14. Newbold RR, Bullock BC, McLachlan JA: Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 1990;50:7677-7681.
15. Shuanfang L, Hansman R, Newbold R, et al: Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog 2003; 38:78-84.
16. Miyagawa S, Katsu Y, Watanabe H, Iguchi T: Estrogen-independent activation of ERβ signaling and estrogen receptor a in the mouse vagina exposed neonatally to diethylstilbestrol. Oncogene 2004;23: 340-349.
17. Newbold RR, Moore AB, Dixon D: Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES). Toxicol Pathol 2002;30:611-616.
18. Cook J, Davis BJ, et al: Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance. Proc Natl Acad Sci USA 2005;102:8644-8649.
19. Iguchi T, Kamiya K, Uesugi Y, et al: In vitro fertilization of oocytes from polyovular follicles in mouse ovaries exposed neonatally to diethylstilbestrol. In Vitro 1991;5:359-363.
20. Nagai A, Ikeda Y, Aso T, Eto K, Ikeda MA: Exposure of neonatal rats to diethylstilbestrol affects the expression of genes involved in ovarian differentiation. J Med Dent Sci 2003;50:35-40.
21. Birnbaum LS, Fenton SE: Cancer and developmental exposures to endocrine disruptors. Environ Health Perspect 2003;111:389-394.
22. Vandenberg LN, Maffini MV, Wadia PR, Son-nenschein C, Rubin BS, Soto AM: Exposure to environmentally relevant doses of the xenoestrogen bisphenol A alters development of the fetal mouse mammary gland. Endocrinol 2007;148:116-127.
23. Durando M, Kass L, Viva J, et al: Prenatal bisphenol A exposures induce preneoplastic lesions in the mammary gland in Wistar rats. Environ Health Perspect 2007;115:80-86.
24. Fenton SE, Hamm JT, Birnbaum LS Youngblood GL: Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 2002;67:63-74.
25. Newbold RR, Padilla-Banks E, Jefferson WN: Adverse effects of the model environmental estrogen diethylstilbestrol (DES) are transmitted to subsequent generations. Endocrinology 2006;147:S11-S17.
26. Palmer JR, Hatch EE, Rosenberg CL, et al: Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes Control 2002;13:753-758.
27. Hung-Shu C, Anway MD, Rekow SS, Skinner MK: Transgenerational epigenetic imprinting of the male germ-line by endocrine disruptor exposure during gonadal sex determination. Endocrinol 2006;147: 5524-5541.
28. Oken E, Gillman MW: Fetal origins of obesity. Obes Res 2003;11:496-506.
29. Ahima RS: Central actions of adipocyte hormones. Trends Endocrinol Metab 2005;16:307-313.
30. Yura S, Itoh H, Sagawa N, et al: Role of premature leptin surge in obesity resulting from intrauterine undernutrition. Cell Metab 2005;1:371-378.
31. Grun F, Blumberg B: Perturbed nuclear receptor signaling by environmental obesogens as emerging factors in the obesity crisis. Rev Endocr Metab Disord 2007;8:161-171.
32. Baillie-Hamilton PF: Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 2002;8:185-192.
33. Newbold RR, Padilla-Banks E, Snyder RJ, Jefferson WN: Perinatal exposure to environmental estrogens and the development of obesity. Mol Nutr Food Res 2007;51:912-917.
34. Penza M, Montani C, Romani A, et al: Genistein affects adipose tissue deposition in a dose dependent and gender specific manner. Endocrinology 2006;147:5740-5751.
35. Rubin BR, Murray MK, Damassa DA, King JC, Soto A: Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ Health Perspect 2001;109:675-680.
36. Sakurai K, Kawazuma T, Adachi T, et al: Bishenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 2004;141:209-214.
37. Masuno H, Kidani T, Sekiya K, et al: Bisphenol A in combination with insulin can accelerate the conversion of 3T3 L1 fibroblasts to adipocytes. J Lipid Res 2002;43:676-684.
38. Grun F, Watanabe H, Samarian Z, et al: Endocrine disrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 2006;20:2141-2155.